位置:首页 > 蛋白库 > NEOEP_STRFR
NEOEP_STRFR
ID   NEOEP_STRFR             Reviewed;         299 AA.
AC   Q53U14;
DT   07-JAN-2015, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   03-AUG-2022, entry version 65.
DE   RecName: Full=Neomycin C epimerase {ECO:0000305|PubMed:25230155};
DE            EC=5.1.3.- {ECO:0000269|PubMed:25230155};
DE   AltName: Full=Radical S-adenosyl-L-methionine epimerase NeoN {ECO:0000303|PubMed:25230155};
DE            Short=Radical SAM epimerase NeoN {ECO:0000303|PubMed:25230155};
GN   Name=neoN {ECO:0000303|PubMed:25230155, ECO:0000312|EMBL:CAF33317.1};
GN   Synonyms=neoH {ECO:0000312|EMBL:BAD95825.1};
OS   Streptomyces fradiae (Streptomyces roseoflavus).
OC   Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC   Streptomyces.
OX   NCBI_TaxID=1906;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 10745 / CBS 498.68 / DSM 40063 / JCM 4133 / NBRC 12773 / NCIMB
RC   8233 / NRRL B-1195 / VKM Ac-150;
RA   Aboshanab K.M., Schmidt-Beissner H., Wehmeier U.F., Piepersberg W.,
RA   Welzel K., Vente A.;
RT   "Analysis and comparison of biosynthetic gene clusters for the 2-deoxy-
RT   inosamine containing aminoglycoside antibiotics ribostamycin, neomycin,
RT   lividomycin, paromomycin and butirosin.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 10745 / CBS 498.68 / DSM 40063 / JCM 4133 / NBRC 12773 / NCIMB
RC   8233 / NRRL B-1195 / VKM Ac-150;
RA   Subba B., Kharel M.K., Sthapit B., Liou K., Lee H.C., Woo J.S., Sohng J.K.;
RT   "Cloning and characterization of a neomycin biosynthetic gene cluster from
RT   Streptomyces fradiae, ATCC 10745.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 10745 / CBS 498.68 / DSM 40063 / JCM 4133 / NBRC 12773 / NCIMB
RC   8233 / NRRL B-1195 / VKM Ac-150;
RX   PubMed=16506694; DOI=10.1038/ja.2005.104;
RA   Kudo F., Yamamoto Y., Yokoyama K., Eguchi T., Kakinuma K.;
RT   "Biosynthesis of 2-deoxystreptamine by three crucial enzymes in
RT   Streptomyces fradiae NBRC 12773.";
RL   J. Antibiot. 58:766-774(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 10745 / CBS 498.68 / DSM 40063 / JCM 4133 / NBRC 12773 / NCIMB
RC   8233 / NRRL B-1195 / VKM Ac-150;
RX   PubMed=15827636; DOI=10.1039/b501199j;
RA   Huang F., Haydock S.F., Mironenko T., Spiteller D., Li Y., Spencer J.B.;
RT   "The neomycin biosynthetic gene cluster of Streptomyces fradiae NCIMB 8233:
RT   characterisation of an aminotransferase involved in the formation of 2-
RT   deoxystreptamine.";
RL   Org. Biomol. Chem. 3:1410-1418(2005).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, REACTION MECHANISM, ACTIVE SITE,
RP   AND MUTAGENESIS OF 26-CYS--CYS-33 AND CYS-249.
RC   STRAIN=ATCC 10745 / CBS 498.68 / DSM 40063 / JCM 4133 / NBRC 12773 / NCIMB
RC   8233 / NRRL B-1195 / VKM Ac-150;
RX   PubMed=25230155; DOI=10.1021/ja507759f;
RA   Kudo F., Hoshi S., Kawashima T., Kamachi T., Eguchi T.;
RT   "Characterization of a radical S-adenosyl-L-methionine epimerase, NeoN, in
RT   the last step of neomycin B biosynthesis.";
RL   J. Am. Chem. Soc. 136:13909-13915(2014).
CC   -!- FUNCTION: Catalyzes the last step of neomycin B biosynthesis, i.e. the
CC       irreversible epimerization at C-5''' of neomycin C to give neomycin B.
CC       To a lesser extent, is also able to convert neomycin Y2 to neomycin Y1.
CC       {ECO:0000269|PubMed:25230155}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=AH2 + neomycin C + S-adenosyl-L-methionine = 5'-deoxyadenosine
CC         + A + H(+) + L-methionine + neomycin B; Xref=Rhea:RHEA:47692,
CC         ChEBI:CHEBI:13193, ChEBI:CHEBI:15378, ChEBI:CHEBI:17319,
CC         ChEBI:CHEBI:17499, ChEBI:CHEBI:57844, ChEBI:CHEBI:59789,
CC         ChEBI:CHEBI:65077, ChEBI:CHEBI:87835;
CC         Evidence={ECO:0000269|PubMed:25230155};
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000269|PubMed:25230155};
CC       Note=Binds 2 [4Fe-4S] clusters. One cluster is coordinated with 3
CC       cysteines and an exchangeable S-adenosyl-L-methionine. The second
CC       cluster is proposed to be involved in the electron-transfer mechanism
CC       for the catalytic cycle. {ECO:0000269|PubMed:25230155};
CC   -!- PATHWAY: Antibiotic biosynthesis; neomycin biosynthesis.
CC       {ECO:0000303|PubMed:25230155}.
CC   -!- SIMILARITY: Belongs to the radical SAM superfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB211959; BAD95825.1; -; Genomic_DNA.
DR   EMBL; AJ629247; CAF33317.1; -; Genomic_DNA.
DR   EMBL; AJ786317; CAH05096.1; -; Genomic_DNA.
DR   EMBL; AJ843080; CAH58695.1; -; Genomic_DNA.
DR   RefSeq; WP_031132490.1; NZ_MUNC01000172.1.
DR   AlphaFoldDB; Q53U14; -.
DR   SMR; Q53U14; -.
DR   KEGG; ag:BAD95825; -.
DR   UniPathway; UPA00969; -.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0016853; F:isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.20.20.70; -; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR000385; MoaA_NifB_PqqE_Fe-S-bd_CS.
DR   InterPro; IPR007197; rSAM.
DR   Pfam; PF04055; Radical_SAM; 1.
DR   SFLD; SFLDS00029; Radical_SAM; 1.
DR   PROSITE; PS01305; MOAA_NIFB_PQQE; 1.
DR   PROSITE; PS51918; RADICAL_SAM; 1.
PE   1: Evidence at protein level;
KW   4Fe-4S; Antibiotic biosynthesis; Iron; Iron-sulfur; Isomerase;
KW   Metal-binding; S-adenosyl-L-methionine.
FT   CHAIN           1..299
FT                   /note="Neomycin C epimerase"
FT                   /id="PRO_0000431421"
FT   DOMAIN          10..222
FT                   /note="Radical SAM core"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01266"
FT   ACT_SITE        249
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000303|PubMed:25230155"
FT   BINDING         26
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="1"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000303|PubMed:25230155, ECO:0000305"
FT   BINDING         30
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="1"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000303|PubMed:25230155, ECO:0000305"
FT   BINDING         33
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="1"
FT                   /ligand_note="4Fe-4S-S-AdoMet"
FT                   /evidence="ECO:0000303|PubMed:25230155, ECO:0000305"
FT   BINDING         226
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000303|PubMed:25230155"
FT   BINDING         247
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000303|PubMed:25230155"
FT   BINDING         271
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000303|PubMed:25230155"
FT   BINDING         274
FT                   /ligand="[4Fe-4S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:49883"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000303|PubMed:25230155"
FT   MUTAGEN         26..33
FT                   /note="CNIRCTYC->ANIRATYA: Loss of enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:25230155"
FT   MUTAGEN         249
FT                   /note="C->A: Reacts with neomycin C, but generates a new
FT                   enzymatic product and not neomycin B."
FT                   /evidence="ECO:0000269|PubMed:25230155"
SQ   SEQUENCE   299 AA;  34363 MW;  A1F806B2BE28A2ED CRC64;
     MTTDIVWPPP VRQVRAYRNI VVDGACNIRC TYCEVKKTKV DQPATIRSLD RIFAEYEPDA
     VLFRVESDGE ITLYPKIVDH LQKRAAEGYR VEVLSNGTKL PRALEGRPDL LWVFSVDGHT
     EAMNAKRGLK QPQIDRILDA AVELGAELQT VYWGQPVEEV NAYIDLLESR GYRGLLHFMP
     LLAFKGRPLT VNLRYQDLHP ADFLAPPEYF RRWNHIFETG RRDAVCDQIT NGYNYQVSGD
     EIRMVKCDCY SVPKHLVHGF GPIREFDDWP CGTCIANQEF NNSRERMRVP QGRIPLPLV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024